Adults prescribed a GLP-1 agent had a 12% higher risk for developing a new chronic cough -- one that persists for over 8 ...

On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...

Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

Our survey has highlighted shifts in the nature of drug use in England, the types of drugs adults take and their dependence ...

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

The Stanford researchers developed a surgical strike to replace the nuke. They used an antibody called anti-CD117 to target ...

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...

Young people may be uniquely vulnerable to ultra-processed foods and more likely to overeat when consuming a diet high in ...

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type ...

Police said they raided an apartment after trying to apprehend a wanted man and finding multiple people allegedly fleeing toward an apartment building.